Valuation: BICO Group AB

Market Cap 1.1B 109M 98.78M 91.25M 82.32M 155M 10.17B 161M 435M 5.49B 408M 400M 17.33B P/E 2026 *
-2.82x
P/E 2027 * -7.87x
Enterprise Value 1.09B 108M 98.15M 90.67M 81.8M 154M 10.1B 160M 432M 5.45B 406M 397M 17.22B EV / Sales 2026 *
0.69x
EV / Sales 2027 * 0.65x
Free-Float
69.88%
Yield 2026 *
-
Yield 2027 * -
1 day-22.63%
1 week-22.63%
Current month-22.37%
1 month-32.46%
3 months+29.45%
6 months-26.55%
Current year-14.06%
1 week 0.48
Extreme 0.4774
0.48
1 month 0.48
Extreme 0.4774
0.67
Current year 0.35
Extreme 0.35
0.71
1 year 0.35
Extreme 0.35
0.71
3 years 0.35
Extreme 0.35
1.55
5 years 0.35
Extreme 0.35
10.56
10 years 0.35
Extreme 0.35
14.8
Manager TitleAgeSince
Chief Executive Officer 51 31/08/2026
Director of Finance/CFO 56 28/02/2026
Chief Operating Officer - 06/01/2026
Director TitleAgeSince
Director/Board Member 71 17/12/2019
Director/Board Member 37 28/02/2015
Director/Board Member 51 06/05/2026
Change 5-day change 1-year change 3-year change Capi.($)
-22.63%-22.63% - - 109M
-0.25%-3.99%+21.58%+47.84% 256B
-1.45%-4.26%+2.55%+8.80% 162B
-1.26%-3.92%-20.91%+41.64% 152B
-1.06%-3.18%-57.47%-20.35% 63.33B
-0.29%+2.87%+26.26%+59.93% 61.59B
-1.59%+0.84%+3.64%-13.47% 53.86B
-0.15%-2.94%+19.47%+52.59% 48.75B
-2.02%-4.11%+5.77%+65.96% 48.46B
-0.61%-5.18%+19.29%+72.17% 44.56B
Average -3.14%-0.29%+2.24%+35.01% 99B
Weighted average by Cap. -0.91%-0.31%+3.40%+34.43%

Financials

2026 *2027 *
Net sales 1.58B 156M 142M 131M 118M 223M 14.61B 232M 625M 7.88B 587M 574M 24.91B 1.58B 156M 142M 131M 118M 223M 14.6B 232M 624M 7.88B 586M 574M 24.89B
Net income -390M -38.63M -35.07M -32.39M -29.22M -55.17M -3.61B -57.28M -154M -1.95B -145M -142M -6.15B -95.3M -9.43M -8.56M -7.91M -7.13M -13.47M -881M -13.99M -37.69M -475M -35.38M -34.64M -1.5B
Net Debt -7M -693K -629K -581K -524K -989K -64.72M -1.03M -2.77M -34.93M -2.6M -2.54M -110M -72M -7.13M -6.47M -5.98M -5.39M -10.18M -666M -10.57M -28.48M -359M -26.73M -26.17M -1.13B
Projected Income Statement - Annual - BICO Group AB
Logo BICO Group AB
BICO Group AB, previously Cellink AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company focuses on the application areas of bioprinting, multiomics, cell line development, and diagnostics. The Company develops and markets technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. The Company’s operations divided in two segments: The Industrial Solutions segment that offers products within precision dispensing and biosensor technology for industrial customers, which make a high-capacity contribution to customers production; and The Laboratory Solutions segment that offers 3Dprinters, single- cell and liquid- dispensing instruments as well as services and consumables related to these products.
Employees
554
Date Price Change Volume
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - BICO Group AB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
15.58SEK
Average target price
31.50SEK
Spread / Average Target
+102.18%